Nextron Infusion Services Revenue and Competitors

Fairfield, NJ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Nextron Infusion Services's estimated annual revenue is currently $13.4M per year.(i)
  • Nextron Infusion Services's estimated revenue per employee is $243,000

Employee Data

  • Nextron Infusion Services has 55 Employees.(i)
  • Nextron Infusion Services grew their employee count by 4% last year.

Nextron Infusion Services's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M52-4%N/AN/A
#2
$275.2M72828%N/AN/A
#3
$35.9M13310%N/AN/A
#4
$11050M288364%$48.1MN/A
#5
$18.2M7521%N/AN/A
#6
$17M703%N/AN/A
#7
$25.1M93-10%N/AN/A
#8
$24M8910%N/AN/A
#9
$17M7015%N/AN/A
#10
$9.7M45-6%N/AN/A
Add Company

What Is Nextron Infusion Services?

The number one independent home infusion company in New Jersey with over one million professional infusions provided and the most experienced network of nurses in the State. Nextron has been providing home infusion services since 1990, specializing in administering IV antibiotics, TPN, IVIG, Remicade, Chemotherapy and other intravenous medications. Nextron pharmacy mixes each individual's medications when ordered, and can accommodate same day and next day delivery, simplifying same day discharges! From start to finish, Nextron makes the at home IV therapy experience seamless for the doctor and the patient. We verify insurance, out of pocket costs, deductibles and apply for any needed authorizations for the patient. Nextron pharmacy mixes patient medication individually and personally delivers it to the home with a intensive nurse to administer the IV and do patient teaching. We pride ourselves on making the patient and doctor's roles as easy as possible!

keywords:N/A

N/A

Total Funding

55

Number of Employees

$13.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.4M5512%N/A
#2
$7.2M5517%N/A
#3
$13.4M55-10%N/A
#4
$13.4M550%N/A
#5
$10.3M562%N/A